Health Care • Medical/Nursing Services
$15.50 ▲ +0.20
(+1.31%)
MKT CAP: $46.4M • VOL: 45.0K
52W L $5 52W H $71
ROARABLE / RQD
D- • 39/100
PIOTROSKI
4 / 9
EUDA // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $6.8M | $4.0M | $3.7M |
| YoY Revenue Growth % | +70.0% | +8.2% | — |
| Gross Profit | $3.0M | $762.2K | — |
| Gross Margin % | 43.9% | 19.0% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$2.5M | -$17.3M | -$4.0M |
| Operating Margin % | -36.3% | -80.0% | -80.0% |
| Net Income (GAAP) | -$2.8M | -$15.4M | -$10.0M |
| EBITDA (Normalized) | -$2.4M | -$17.3M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$2.4M | -$2.0M | -$2.9M |
| Capital Expenditures (CapEx) | $77.3K | $96.8K | — |
| Free Cash Flow (FCF) | -$2.5M | -$2.1M | -$2.9M |
| FCF Margin % | -36.7% | -53.1% | -78.7% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | — | — | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | -$4.3M | -$2.6M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR EUDA.